Please login to the form below

Not currently logged in
Email:
Password:

Europe delays EMA relocation decision

Will resolve the issue in November, one month later than expected

EMAThe decision on which country will host Europe’s pharma regulator once the UK leaves the European Union has been postponed by one month.

Currently based in London, the European Medicines Agency (EMA) is now expected to learn later this year in November where it will be moved to.

The decision will be taken at a meeting of the heads of state or government from the 27 states that will make up the EU after March 29, 2019, and its delay has prompted pharma to voice its concern.

European trade body EFPIA acknowledged the complexity of the Brexit negotiations, but argued in a statement “medicines constitute a special case in term of securing swift agreement on both sides”.

“It is imperative for the safeguarding of public health that we ensure future alignment between the UK and EU regulatory regimes in order to maintain capacity, processes and timeframes for the introduction of new medicines for patients,” it added.

Echoing this Dr Virginia Acha, executive director of research, medicine and innovation at the UK’s ABPI, said: “It will be critical to avoid divergence and duplication of regulatory regimes, so that patient safety is not put at risk."

The EU’s November meeting will also see the post-Brexit location decided of the European Banking Authority (EBA), which must leave London too.

EU member states can bid to host both, but - with the EMA’s fate to be decided first - the country that wins the right to the medicines regulator cannot then continue with its bid for the EBA.

Countries that have so far thrown their hats into the ring for the EMA contest include Copenhagen, Barcelona, Lisbon and Dublin - any more that are interested have until July 31 to submit their offer.

Article by
Dominic Tyer

26th June 2017

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

Digital
Tools for the digital world
The next step for the pharma industry...
How Can We Make Payer Communications Really Sing?
With so many different influences at play in access decisions, how can we make sure we tap into what’s really driving payer decision-making. How do we go beyond the stated...
Harnessing the power of core elements to optimise market access
This article by John Spoors and Anton Abrahams focuses on optimising market access – the RJW and Solaris Health teams operate across all major markets, where the principles set out...

Infographics